Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin‐34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony‐Stimulating Factor Receptor
Katrien Van Raemdonck, Sadiq Umar, Karol Palasiewicz, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 11, pp. 2003-2014
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury
Wenjing Zhong, Tian Liu, Hui‐Hui Yang, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 242-257
Open Access | Times Cited: 78
Pathogenesis of rheumatoid arthritis: one year in review 2022
Fiorella Petrelli, Francesco Mariani, Alessia Alunno, et al.
Clinical and Experimental Rheumatology (2022) Vol. 40, Iss. 3, pp. 475-482
Open Access | Times Cited: 55
Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases
Caigui Xiang, Heng Li, Wei Tang
Pharmacological Research (2022) Vol. 187, pp. 106566-106566
Open Access | Times Cited: 49
Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
Zhijia Xia, Shi Chen, Miao He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 37
Multifunctional Nanoplatform for Mild Microwave-Enhanced Thermal, Antioxidative, and Chemotherapeutic Treatment of Rheumatoid Arthritis
Lianying Zhang, Wei Meng, Xiaotong Chen, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 8, pp. 10341-10355
Closed Access | Times Cited: 22
Triglyceride-glucose index in the prediction of new-onset arthritis in the general population aged over 45: the first longitudinal evidence from CHARLS
Yang Liu, Junjie Yao, Xiaona Xue, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Glycolysis in Innate Immune Cells Contributes to Autoimmunity
Yue Xu, Yongkang Chen, Xuan Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types
Sadiq Umar, Karol Palasiewicz, Michael V. Volin, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 23, pp. 7693-7707
Open Access | Times Cited: 38
Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis
Anja Meyer, Stephanie R. Zack, Wes Nijim, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 1, pp. 33-46
Closed Access | Times Cited: 13
IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway
Ruisong Ma, Xiaochun Hu, Wenwen Fu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0315489-e0315489
Open Access
Application of cell therapy in rheumatoid Arthritis: Focusing on the immunomodulatory strategies of Mesenchymal stem cells
Feng Zhi, Ying Yang, X. Liu, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114017-114017
Closed Access
IRAK4 inhibitor mitigates joint inflammation by rebalancing metabolism malfunction in RA macrophages and fibroblasts
Sadiq Umar, Karol Palasiewicz, Michael V. Volin, et al.
Life Sciences (2021) Vol. 287, pp. 120114-120114
Open Access | Times Cited: 24
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells
Anja Meyer, Ryan E Sienes, Wes Nijim, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 4, pp. 483-495
Open Access | Times Cited: 10
Role of IL-34 and its receptors in inflammatory diseases
Jiameng Shang, Yuxin Xu, Sheng‐Dan Pu, et al.
Cytokine (2023) Vol. 171, pp. 156348-156348
Closed Access | Times Cited: 9
IL-34 attenuates acute T cell-mediated rejection following renal transplantation by upregulating M2 macrophages polarization
Bing Ni, Dongliang Zhang, Hai Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24028-e24028
Open Access | Times Cited: 3
Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming
Sadiq Umar, Karol Palasiewicz, Anja Meyer, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 15
Glycobiology in osteoclast differentiation and function
Shufa Yang, Ziyi He, Tuo Wu, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Interleukin-34-regulated T-cell responses in rheumatoid arthritis
Hye Eun Park, Hanna Oh, Jea-Hyun Baek
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut
Eleonora Franzè, Federica Laudisi, Rachele Frascatani, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1698-1698
Open Access | Times Cited: 1
IL-34 and protein-tyrosine phosphatase receptor type-zeta-dependent mechanisms limit arthritis in mice
Hilda M. González-Sánchez, Jea-Hyun Baek, Julia Weinmann‐Menke, et al.
Laboratory Investigation (2022) Vol. 102, Iss. 8, pp. 846-858
Open Access | Times Cited: 7
Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritis
Brianna M. Hurysz, Nunzio Bottini
AJP Cell Physiology (2022) Vol. 322, Iss. 6, pp. C1061-C1067
Open Access | Times Cited: 7
Dysregulation of IL-34 ligation to SDC-1 mitigates collagen-induced arthritis
Anja Meyer, Ryan E Sienes, Brian Zanotti, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 1070-1072
Open Access | Times Cited: 7
HIF-1α mediates osteoclast-induced disuse osteoporosis via cytoophidia in the femur of mice
Miaomiao Bie, Yi Tang, Yuxing Xia, et al.
Bone (2022) Vol. 168, pp. 116648-116648
Open Access | Times Cited: 7
Metabolic reprogramming of macrophages instigates CCL21‐induced arthritis
Katrien Van Raemdonck, Sadiq Umar, Karol Palasiewicz, et al.
Immunology and Cell Biology (2021) Vol. 100, Iss. 2, pp. 127-135
Open Access | Times Cited: 6
Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models
Osama Alzoubi, Anja Meyer, Tanya Pulido Gonzalez, et al.
Clinical Immunology (2023) Vol. 251, pp. 109635-109635
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top